Recommended Medications for Neuropathic Pain
First-line medications for neuropathic pain include tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors (SNRIs), and gabapentinoids (pregabalin and gabapentin). 1
First-Line Medications
Gabapentinoids
Pregabalin
- Starting dose: 50-75 mg twice daily
- Target dose: 300-600 mg/day (divided doses)
- FDA-approved for diabetic peripheral neuropathy, postherpetic neuralgia, and neuropathic pain associated with spinal cord injury 2
- Dose adjustments needed for renal impairment 2
- "Low and slow" titration recommended to minimize side effects 3
Gabapentin
Antidepressants
Tricyclic Antidepressants (TCAs)
SNRIs
Medication Selection Algorithm
Initial Selection:
- For most neuropathic pain conditions: Start with either pregabalin/gabapentin OR duloxetine/TCA
- For diabetic neuropathy: Consider duloxetine as first choice
- For postherpetic neuralgia: Consider gabapentinoids as first choice
- For elderly patients: Avoid TCAs due to anticholinergic effects; prefer gabapentinoids or duloxetine
Titration Strategy:
- Pregabalin: Start 50-75 mg BID, increase weekly to target 300-600 mg/day 2, 3
- Gabapentin: Start 300 mg daily, increase to 900 mg/day by day 3, then titrate to 1800-3600 mg/day as needed 4
- Duloxetine: Start 30 mg daily for one week, then increase to 60 mg daily 1
- TCAs: Start 10-25 mg at bedtime, increase gradually to 75 mg/day 1
Inadequate Response:
- If initial medication at maximum tolerated dose for 4 weeks provides insufficient relief:
- Switch to alternative first-line agent from different class
- Consider combination therapy (e.g., gabapentinoid + antidepressant)
- If initial medication at maximum tolerated dose for 4 weeks provides insufficient relief:
Dosing Pearls and Pitfalls
Pregabalin
- Many patients require dose escalation for optimal effect
- Patients who don't respond to lower doses often show notable improvement when dose is escalated 5
- Asymmetric dosing (larger dose in evening) may improve tolerability 3
- Common side effects: dizziness (23.1%), drowsiness (14.6%), peripheral edema (10.4%) 6
Gabapentin
- Requires three-times-daily dosing for optimal effect
- Never discontinue abruptly; taper over at least 1 week 1
- Therapeutic effects may take several days to weeks to develop 1
TCAs
- Monitor for anticholinergic side effects, especially in elderly
- Take at bedtime to minimize daytime sedation
- Contraindicated in patients with cardiac conduction abnormalities
Duloxetine
- Contraindicated in liver disease
- Requires dose adjustment in renal impairment 1
- Should never be stopped abruptly; taper gradually 1
Special Populations
- Elderly patients: More susceptible to side effects; require lower doses 1
- Patients with renal impairment: Require dose adjustments for gabapentinoids 2
- Patients with liver disease: Avoid duloxetine 1
- Patients on anticoagulants: Use duloxetine with caution due to bleeding risk 1